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Abstract  
Just as the internet has transformed how we communicate and share, it is now transforming how 
we work, and of course, how we shop and particularly, in the healthcare sector, this theme is 
becoming prominent. Starting from two observed events: 1. the growing market demand of 
healthy products toward internet channels and 2. the importance to safely regulate that market, to 
prevent the danger naturally associated to the drugs sale on the net, the article has been drawn up 
to analyse the future Italian scenario where the OTC pharmaceuticals will be traded online 
(Vagnozzi, 2015) as sustained by the new normative evolution. The environment of the pharmacy 
is undergoing a change due to both the recent possibility to adopt the net as a channel to sell 
pharmaceuticals (prescription ones are not taken into consideration) and the necessity to provide 
responses to the new type of pharmacy-Clients who are more attentive toward the topic.  In this 
situation develops an Internet Pharmacy which is different in the structure as well as in the new 
functions of the pharmacist who should assume a new managerial role, to be able to manage his 
own point of sale .  
 
TERMS AND CONDITIONS OF THE NEW LEGAL ONLINE PHARMACY 
In Italy, online pharmacies will be soon a reality; they will be absolutely legal and regulated by 
the government, on the authority of parliament and in harmony with the European directives. In 
the draft decree for the transposition of Directive 2011/62/EU, approved by the Council of 
Ministers, it is expected, under certain conditions and subject to authorization, the possibility to 
sell pharmaceuticals, without prescription ones (OTC) only allowed, on the internet through 
pharmacies or drugstores. Behind the website, then, there will be always a “physical" shop, 
recognizable and authorized. To come into compliance with the new provisions, and start selling 
online pharmaceuticals, the websites of pharmacies and drugstores will contain a link connected 
to the Ministry of Health website itself, which in turn must contain a list of all entities or persons 
authorized to sell drugs on the net. A special logo, the same for everyone, makes instantly 
recognizable the websites licensed to sell1. Concerning the tasks of the Italian Drug Agency 
(AIFA), measures to increase public awareness about the risks associated with the use of unsafe 
drugs, are needed. 
MARKET TRENDS: Health-related & Pharmaceutical expenditure  
Figure 1 Retail Trade Variations in Italy; Focus on Non Food Products ( 2011- 2013). Data Istat 
 
                                                          
1 On June 24th, 2014, The European Commission implemented the regulation in the context of the Directive on 
falsified pharmaceuticals (Directive 2011/62/EU), which establishes a common logo for  the pharmacies online, as 
well as the technical requirements to ensure its authenticity. The logo will be available from the second half of 
2015. http://europa.eu/rapid/press-release_IP-14-712_it.htm 
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 Figure 2  Retail Trade 2013 . Data Istat 
 Nov 13--Nov 12 Jan-Nov 13--Jan-Nov 12 
Food & Beverages 1,5 -1 
Non Food -0,6 -2,7 
Pharmaceuticals products -1,7 -2,6 
Clothing -0,3 -2,6 
Footwear, Leather goods and luggage -0,1 -2,9 
Furniture, textile -0,8 -3,3 
Appliances, radio, TV and Recorders 0,1 -3,1 
Computers, Telephones, Telecommunications -0,3 -1,4 
Photo-optical, Films, Magnetic Media and Musical instruments -1,2 -3,4 
Household goods, durables and non- durables -0,1 -2,3 
house tools and other 0,2 -1,8 
Perfumery and personal care goods 1,2 -1 
Books, magazines and newspapers -2,8 -4,1 
games, toys, sport and camping 1,1 -2,6 
other products (Jewelry, watches) -2,3 -2,9 
total  0,1 -2,1 
 
The indicators showed in the above Figures 1 and 2 (Istat, January 24, 2014), are useful to 
analyze and understand market trends especially in the pharmacy retailing. November 2013 
showed diversified trends for different groups but a more sustained increase concerns groups of 
products like perfumery and personal care (+1.2%). The value of pharmaceuticals items sales, in 
November 2013 compared to the previous year, shows a decline in sales of 2,6 ; while comparing 
the single month of November there is a negative value of 1,7 which is lower but always minus 
signed. Considering the time of international crisis and decline in consumption sales, the choices 
the pharmacy makes become fundamental. The opportunity offered by e-commerce in this sector, 
assumes a strategic value. Moreover, the statistics show that, although retail sales of 
pharmaceuticals have experienced a significant decline, this does not concern the field of 
personal care and perfumery items which, in fact, recorded a sales increase of 1.2 in November. 
That demonstrates the increasing customer’s attention towards these kind of products which 
should be exploited through the Net to improve the performance of service delivered. 
 
 
THE NET IN FIGURES 
Figure 3  E-commerce sales and purchases, 2012 (% of Enterprises) . Source of Eurostat 
 
 
 
 
Figure 4  E-commerce sales to own country and other EU countries, 2012 (% Enterprises). Source of Eurostat 
 
  
HEALTH & WEB, CONSIDERATIONS ON THE SECTOR 
Today the possibilities offered by Internet to the Pharmaceutical Industry are numerous, both in 
Research and Development processes optimization (production and distribution) and in the 
communication improvement, as well as in the business as a whole. The entire pharmaceutical 
sector is evolving towards a model of market in which is in place a substantial change in the 
supply and demand  as well in the roles of main actors involved: health authorities, patients, 
doctors, and industry. The offer will be increasingly marked by new drugs and in the future, 
probably customized. The demand will continue to grow because of an older population and the 
spread of a different concept of health, also understood as wellbeing. The mix generated ,will 
find hard compatibility with the limited public budgets, often inadequate; this will transfer the 
whole pharmaceuticals spending to the consumers, increasing their decision-making role , so as 
geo\time 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013
EU (28 countries) : : : : : 23 24 28 31 33 35 38
EU (27 countries) : : 15 18 20 23 24 28 31 34 35 38
Euro area (changing composition)9 12 : 17 20 23 24 27 31 33 35 38
Belgium : : : 11 14 15 14 25 27 31 33 36
Bulgaria : : 1 : 2 2 2 3 3 5 6 8
Czech Republic : 3 3 3 7 8 13 12 15 16 18 21
Denmark 24 16 22 26 31 43 47 50 54 57 60 65
Germany 17 24 29 32 38 41 42 45 48 54 55 60
Estonia : : 4 4 4 6 7 12 13 16 17 16
Ireland : 5 10 14 21 26 30 29 28 34 35 37
Greece 1 1 1 2 3 5 6 8 9 13 16 17
Spain 2 5 5 8 10 13 13 16 17 19 22 23
France : : : : 19 25 28 32 40 40 42 44
Croatia : : : : : 5 5 6 9 11 16 19
Italy 3 4 : 4 5 7 7 8 9 10 11 14
Cyprus : : 3 4 5 8 7 13 14 16 17 20
Latvia : : 2 3 5 6 10 8 8 10 18 21
Lithuania : 1 1 1 2 4 4 6 7 10 14 19
Luxembourg 13 18 32 31 35 37 36 46 47 52 57 59
Hungary : : 2 5 5 7 8 9 10 13 15 17
Malta : : : 10 9 16 16 27 32 35 37 38
Netherlands 15 18 24 31 36 43 43 49 52 53 52 59
Austria 8 8 13 19 23 26 28 32 32 35 39 46
Poland : : 3 5 9 11 12 18 20 20 21 23
Portugal 2 2 3 4 5 6 6 10 10 10 13 15
Romania : : 0 : 1 2 3 2 2 4 3 5
Slovenia : : 4 8 8 9 12 14 17 20 22 25
Slovakia : : 6 6 7 10 13 16 19 23 30 30
Finland 11 14 24 25 29 33 33 37 41 45 47 49
Sweden 24 21 30 36 39 39 38 45 50 53 58 57
United Kingdom 25 24 28 36 38 44 49 58 60 64 64 71
Iceland : 20 25 28 31 32 32 27 29 31 35 34
Norway : 24 31 35 47 48 46 54 53 57 62 56
Figure 5 Individuals having ordered/bought goods or services for private use over the Internet (% 2014) Data Eurostat 
to assume a more central and crucial role in the system. The so-called "empowered '' patient will 
find on the Internet an informative, communicative, participatory and, sometimes , commercial 
tool i.e. an ideal vehicle for the growing needs, creating significant opportunities for the 
pharmaceutical industry. But today the use of  Internet constitutes, for the sector, an opportunity 
to optimize the efficiency of R&D and production processes, allowing better results at lower 
costs. Analyzing the main processes of the pharmaceutical industry, Internet can contribute to 
make those more effective and efficient, even though in different ways. Even for the 
pharmaceuticals, a real virtual marketplace is growing, the so-called vertical portals or " vortals ", 
which bring together supply and demand of goods and services, aggregating suppliers and 
customers in a logic of greater efficiency and competitiveness . In the supply chain, for example, 
it is believed that the pharmaceutical industry for the supply of raw materials or the production 
and packaging ,will use internet more than the average use of the whole manufacturing industry. 
It is undoubtedly an emblematic phenomenon of this new and growing role of the Net applied to 
Health.   
 User’s Identikit  
However, the type of user who navigates the Net for health related reasons differs significantly 
between the U.S. and Europe, showing how, despite growing empowerment of the patient, the 
doctor still constitutes, in Italy, one of the primary users of Internet for health purposes. In 
Europe the Internet is used  especially by doctors for the health of the patient; generally men surf 
and access the net, from their workplace, more frequently than women. In contrast, in the United 
States, the network is used by patients/ users for personal or family health. The access, in fact, 
takes place especially from their home and equally between men and women. 
 E-pharmacies’ growth hypothesis  
As regards the direct sale to the patient is now premature to imagine a distribution process from 
the manufacturer directly to the final consumer, given the logistical and organizational 
implications that would entail. The existing e-pharmacies are in fact pharmacies that use the web, 
more or less exclusively, to sell drugs bought from wholesalers or directly from manufacturers , 
as well as in the traditional distribution channel, although in Europe and in Italy the initiatives 
began to be numerous.  
Most of the experiences come from the USA. It is interesting to notice that a pure online sale 
business model it has not been particularly profitable, penalized by the costs incurred to advertise 
and to make known their sales sites on the web. Greater success, however, are experiencing the 
hybrid business models, also called click and mortar , consisting in the use of web joined with 
real pharmacies. Nowadays there is an ongoing redesign of web-pharmacies, with the 
introduction aggregation processes intended to reach a critical mass unit which allow bigger 
market positions and investments. Forecasting the volume of e-commerce business in the 
pharmaceutical industry is not easy, given the duplicity and the rapid evolution of the variables 
involved, linked both to Internet and to the sector itself . Many analysts expect a sustained growth; 
even in Italy, given the materialization of the conditions for a price competition, which is 
currently not feasible, the online sale would then become really attractive for the user as well as 
for the third party payer, in the case of drugs dispensed by the NHS , being able to have drugs at 
lower prices through better economies of scale and managerial advantages in the distribution 
chain.  
 
CONCLUSION 
The development of the Internet has seen the birth of online commerce. Each sector has been 
overwhelmed by the wave of Web 2.0, and even in the pharmaceutical world the e-commerce has 
revolutionized the trend of traditional pharmacies, who for years have been the only "home" 
where you could buy the pharmaceuticals or health related products like food supplements, 
innovative cosmetics, sanitary items and everything related to health and beauty. The 
transposition of the European Directive will allow the Italian citizens to be more sure when 
buying drugs online, being able to identify which sites are legal, by means of identifying logo, 
and avoiding the many illegal sites which over the years have caused concern and distrust among 
the users. The digital health is also exploding: app, visits and consultations via web, corporate 
sites, online magazine, blog, social network etc.. but it is important to point out that some 
conditions should be created for the feasibility of an online pharmacy: 1.Confidence, the site must 
benefit from the trust that the customer agrees to the pharmacy and to the pharmacist, in order to 
prevent fear related to eventual illegal behavior, then the site should convey the atmosphere and 
essence of the pharmacy, so it should be appropriate to bring back in full view the address and 
maybe post some pictures of the same pharmacy or its staff. 
2. Information, the consumer must be informed of the presence of a website linked to the 
pharmacy. It should also reassure the legality and legitimacy of the online sale. Adequate 
communication, through portals and sites can encourage the consumer to try the service remotely. 
3.The complementarity, to exploit the good results of certain segments of the commercial area 
(supplements, cosmetics and so on) to boost online sales with an offer of complementary 
products based on practicality (time saving, speed, etc.) or to meet needs that do belong to the 
normal pharmacy shopping. 
All the considerations advanced so far, are based on the growth rate hypothesis regarding the 
online purchase/sale in the pharmaceutical sector presented before, and they represent an 
encouraging incentive for both the pharmacists and the clients, with a broad view of optimal 
advantage for the society as a whole 
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